期刊文献+

AS1411 aptamer-conjugated Gd2O3:Eu nanoparticles for target-specific computed tomography/magnetic resonance/fluorescence molecular imaging 被引量:3

AS1411 aptamer-conjugated Gd2O3:Eu nanoparticles for target-specific computed tomography/magnetic resonance/fluorescence molecular imaging
原文传递
导出
摘要 Europium-doped gadolinium oxide (Gd2O3:Eu) nanoparticles have been synthesized, and then their surfaces have been conjugated with nucleolin- targeted AS1411 aptamer to form functionalized target-specific Gd2OB:EU nanoparticles (A-GdO:Eu nanoparticles). The A-GdO:Eu nanoparticles present strong fluorescence in the visible range, high magnetic susceptibility, X-ray attenuation and good biocompatibility. The A-GdO:Eu nanoparticles have been applied to test molecular expression of nucleolin highly expressed CL1-5 lung cancer cells under a confocal microscope. Fluorescence imaging clearly reveals that the nanoparticles can be applied as fluorescent tags for cancer-targeting molecular imaging. Furthermore, taking together their excellent T1 contrast and strong computed tomography (CT) signal, the A-GdO:Eu nanoparticles demonstrate a great capability for use as a dual modality contrast agent for CT and magnetic resonance (MR) molecular imaging. Animal experiments also show that the A-GdO:Eu nanoparticles are able to contrast the tissues of BALB/c mice using CT modality. Moreover, the obvious red fluorescence of A-GdO:Eu nanoparticles can be visualized in a tumor by the naked eye. Overall, our results demonstrate that the A-GdO:Eu nanoparticles can not only serve as new medical contrast agents but also as intraoperative fluorescence imaging probes for guided surgery in the near future.
出处 《Nano Research》 SCIE EI CAS CSCD 2014年第5期658-669,共12页 纳米研究(英文版)
关键词 APTAMER contrast agent Gd2O3 nanoparticles molecular imaging nanoparticles synthesis 计算机断层扫描 纳米颗粒 荧光成像 分子成像 氧化钆 磁共振 Eu 适体
  • 相关文献

参考文献57

  • 1Seo, W. S.; Lee, J. H.; Sun, X. M.; Suzuki, Y.; Mann, D.; Liu, Z.; Terashima, M.; Yang, P. C.; McConne[l, M. V.; Nishimura, D. G.; Yang, P. C. et al. FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents. Nat. Mater. 2006, 5, 971-976.
  • 2Jun, Y. W.; Lee, J. H.; Cheon, J. Chemical design of nano- particle probes for high-performance magnetic resonance imaging. Angew. Chem. Int. Ed 2008, 47, 5122-5135.
  • 3Hahn, M. A.; Singh, A. K.; Sharma, P.; Brown, S. C.; Moudgil, B. M. Nanoparticles as contrast agents for in-vivo bioimaging: Current status and future perspectives. Anal. Bioanal. Chem. 2011, 399, 3-27.
  • 4Lim, E. K.; Huh, Y. M.; Yang, J.; Lee, K.; Suh, J. S.; Haam, S. pH-Triggered drug-releasing magnetic nanoparticles for cancer therapy guided by molecular imaging by MRI. Adv. Mater. 2011, 23, 2436-2442.
  • 5Xing, H. Y.; Bu, W. B.; Zhang, S. J.; Zheng, X. P.; Li, M.; Chen, F.; He, Q. J.; Zhou, L. P.; Peng, W. J.; Hua, Y. Q. Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. Biomaterials 2012, 33, 1079-1089.
  • 6Hyafil, F.; Cornily, J. C.; Feig, J. E.; Gordon, R.; Vucic, E.; Amirbekian, V.; Fisher, E. A.; Fuster, V.; Feldman, L. J.; Fayad, Z. A. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat. Med. 2007, 13, 636-641.
  • 7Baker, M. Whole-animal imaging: The whole picture. Nature 2010, 463, 977-980.
  • 8Na, H. B.; Hyeon, T. Nanostructured T1 MRI contrast agents. J. Mater. Chem. 2009, 19, 6267-6273.
  • 9Kumar, R.; Roy, I.; Ohulchanskky, T. Y.; Vathy, L. A.; Bergey, E. J.; Sajjad, M.; Prasad, P. N. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 2010, 4, 699-708.
  • 10Lee, Y. C.; Chen, D. Y.; Dodd, S. J.; Bouraoud, N.; Koretsky, A. P.; Krishnan, K. M. The use of silica coated MnO nanoparticles to control MRI relaxivity in response to specific physiological changes. Biomaterials 2012, 33, 3560-3567.

同被引文献9

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部